7 November 2023
Two Authors in Pharmaceutics Awarded the Physiology or Medicine Nobel Prize

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
The Nobel Prize in Physiology or Medicine 2023 was recently awarded to Prof. Dr. Katalin Karikó and Prof. Dr. Drew Weissman for their discoveries regarding nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19, saving millions of lives worldwide.
The laureates found that the chemical conversion of uridine, a nucleotide of mRNA, to pseudouridine, appeared to prevent the body from perceiving the mRNA as an intruder and destroying it, a finding reported in a 2005 seminal paper. Without the unwanted immune response, mRNA can infiltrate the cells to carry out its intended function and provide cells with plans for making proteins.
Two years ago, Pharmaceutics (ISSN: 1999-4923) released a Special Issue “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, featuring ten articles published between August 2021 and February 2022. Prof. Dr. Karikó and her team at the biotech company, BioNTech, published an article for this Special Issue titled “Ribozyme Assays to Quantify the Capping Efficiency of In Vitro-Transcribed mRNA”.
Prof. Dr. Weissman, in collaboration with colleagues at Pennsylvania University and George Mason University, published an article titled “Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids” that appeared in the Special Issue “Dendrimers: A Themed Issue in Honor of Professor Donald A. Tomalia on the Occasion of His 85th Birthday for His Outstanding Achievements in Advancing the Field of Dendrimers”.
We offer our congratulations to this year's recipients of the Physiology or Medicine Nobel Prize!